Harrow, Inc. (HROW)
34.86
+0.86
(+2.53%)
USD |
NASDAQ |
Mar 24, 12:02
Harrow Shareholders Equity (Quarterly) : 52.45M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 647.80M |
| Esperion Therapeutics, Inc. | -301.96M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Theravance Biopharma, Inc. | 296.72M |
| Rhythm Pharmaceuticals, Inc. | 139.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 405.21M |
| Total Liabilities (Quarterly) | 353.12M |
| Debt to Equity Ratio | 4.804 |
| Current Ratio | 2.199 |
| Net Debt Paydown Yield | -0.61% |